SCHEMBL5658619

SCHEMBL5658619

CC(O)N1Cc2ccccc2C1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.58
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 1/20 0.58
TSHR P16473 1/20 0.58
XIAP P98170 1/20 0.58
HKDC1 Q2TB90 1/20 0.58
HSD17B10 Q99714 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
THRB P10828 3/20 0.57
KMT2A Q03164 5/20 0.56
MEN1 O00255 4/20 0.56
SDCBP O00560 3/20 0.55
SDC2 P34741 3/20 0.55
MAPT P10636 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
POLB P06746 1/20 0.50
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5662816 0.92 THRB (0.54) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL120182 0.85 ALOX15 (0.57) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL24834797 0.82 SDCBP (0.55) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL23867096 0.82 SDCBP (0.55) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL22997450 0.82 SDCBP (0.55) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL30856522 0.81 ALOX15 (0.66) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL2013546 0.81 ALOX15 (0.66) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL311675 0.81 ALOX15 (0.66) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL15338689 0.81 ALOX15 (0.57) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL31667158 0.81 NPC1 (0.54) ALOX15KDM4EALDH1A1TSHRXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166617-B2 Cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2007-01-23 US disclosed
US-20030212094-A1 Novel cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2003-11-13 US disclosed
EP-1260512-A1 NOVEL CYCLIC AMIDE DERIVATIVES Mitsubishi Pharma Corporation (JP) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212094-A1 Novel cyclic amide derivatives SIGMAR1, OPRM1, OPRD1 ALOX15 1648/4885KDM4E 2058/4885ALDH1A1 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.